Cargando…
Remote monitoring using donor-derived, cell-free DNA after kidney transplantation during the coronavirus disease 2019 pandemic
BACKGROUND: Donor-derived, cell-free DNA (dd-cfDNA) level correlates with allograft injury with clinical validity and utility for quiescence and active acute rejection (AR) in kidney transplant recipients. We analyzed trends in dd-cfDNA level immediately preceding and during the coronavirus disease...
Autores principales: | Potter, Steven R., Hinojosa, Randall, Miles, Cliff D., O’Brien, Dan, Ross, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Nephrology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770990/ https://www.ncbi.nlm.nih.gov/pubmed/33303727 http://dx.doi.org/10.23876/j.krcp.20.107 |
Ejemplares similares
-
The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
por: Kueht, Michael L., et al.
Publicado: (2022) -
Identification of Kidney Transplant Recipients with Coronavirus Disease 2019
por: Zhang, Hui, et al.
Publicado: (2020) -
Impact of Remote Ischemic Preconditioning Conducted in Living Kidney Donors on Renal Function in Donors and Recipients Following Living Donor Kidney Transplantation: A Randomized Clinical Trial
por: Bang, Ji-Yeon, et al.
Publicado: (2019) -
Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients
por: Zwart, Tom C., et al.
Publicado: (2022) -
Risk of Severe Coronavirus Disease 2019 Infection in Kidney Transplant Recipients
por: Sacristán, Pilar Galindo, et al.
Publicado: (2022)